UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92–02

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2133-2140

2004

Volltextzugriff (PDF)

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG Oncology/RTOG 9202

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S44-S44

2015

Volltextzugriff (PDF)

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S46-S46

2015

Volltextzugriff (PDF)

Effect of Long-term Hormonal Therapy (vs Short-term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on RTOG 9202

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S26-S26

2013

Volltextzugriff (PDF)

Gleason Pattern 5 is Associated With an Increased Risk for Metastasis Following Androgen Deprivation Therapy (ADT) and Radiation: An Analysis of RTOG 9202 and 9902

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S91-S92

2012

Volltextzugriff (PDF)

Diabetes and Cardiovascular Mortality in Men With Locally Advanced Prostate Cancer: Updated Analysis From RTOG 92-02

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S94-S94

2012

Volltextzugriff (PDF)

Surrogate End-points for Prostate Cancer Specific Survival: Superiority of the Interval to Biochemical Failure: An Analysis of RTOG 9202 and 9413

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S103-S103

2011

Volltextzugriff (PDF)

The Influence of Age as a Predictor of Outcome in Prostate Cancer Patients Treated on RTOG Trials

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S175-S175

2007

Volltextzugriff (PDF)

Cardiovascular Mortality Following Androgen Deprivation Therapy in Men With Locally Advanced Prostate Cancer: An Analysis of RTOG 85-31

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S170-S171

2007

Volltextzugriff (PDF)

Surrogate Endpoints for Prostate Cancer Survival: A Secondary Analysis of RTOG 9202

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S81-S82

2007

Volltextzugriff (PDF)

Tumor and treatment factors improving outcome in stage III-B cervix cancer

International journal of radiation oncology, biology, physics, 1991, Vol.20 (1), p.95-100

1991

Volltextzugriff (PDF)

Carcinoma of the cervix: Patterns of care studies: Review of 1978, 1983, and 1988–1989 surveys

International journal of radiation oncology, biology, physics, 1995-07, Vol.32 (5), p.1481-1486

1995

Volltextzugriff (PDF)

The impact of radiation dose on survival following conformal treatment of prostate cancer

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.S168-S169

2004

Volltextzugriff (PDF)

65

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S38

2006

Volltextzugriff (PDF)

Prognostic factors in carcinoma of the prostate— analysis of rtog study 75-06

International journal of radiation oncology, biology, physics, 1987-03, Vol.13 (3), p.339-349

1987

Volltextzugriff (PDF)

65: Temporal Profile of Serum Testosterone With Goserelin Use and Cessation: Analysis of Radiation Therapy Oncology Group Protocol 92-02

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S38-S38

2006

Volltextzugriff (PDF)

2196

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S318

2006

Volltextzugriff (PDF)

2196: Comparison of Two Types of Biochemical Failures Within the ASTRO and Phoenix Consensus Definitions in Patients Treated on RTOG 92–02 and 94–13

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S318-S318

2006

Volltextzugriff (PDF)

54 The radiation dose response of the human cervical spinal cord

International journal of radiation oncology, biology, physics, 1999, Vol.45 (3), p.174-175

1999

Volltextzugriff (PDF)

1124

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S202

2006

Volltextzugriff (PDF)

22

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S13

2006

Volltextzugriff (PDF)

Post-radiotherapy PSA nadir remains highly predictive of outcome in men who are biochemically free of disease at 1.5 years post-treatment

International journal of radiation oncology, biology, physics, 2003-10, Vol.57 (2), p.S397-S397

2003

Volltextzugriff (PDF)

Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with 3D conformal radiation therapy

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.289-289

2001

Volltextzugriff (PDF)

Late GI and GU morbidity profiles in prostate cancer patients treated with 3D-CRT to 81-84 Gy by a 4-field beam arrangement

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.278-279

2001

Volltextzugriff (PDF)

Highly predictive biochemical indicators of distant metastasis and death due to prostate cancer

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.113-114

2001

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(139)

Publikationsform

Artikel
(149)

Sprache

Englisch
(149)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Science & Technology
(31)
Life Sciences & Biomedicine
(29)
Male
(29)
Biological And Medical Sciences
(26)
Medical Sciences
(25)
Oncology
(22)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Prostatic Neoplasms - Radiotherapy
(19)
Radiology
(18)
Radiotherapy
(18)
Nephrology. Urinary Tract Diseases
(16)
Tumors Of The Urinary System
(16)
Middle Aged
(15)
Urinary Tract. Prostate Gland
(14)
Aged
(13)
Prostatic Neoplasms - Pathology
(12)
Female
(11)
Adult
(9)
Hematology, Oncology And Palliative Medicine
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92–02

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG Oncology/RTOG 9202

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials

Effect of Long-term Hormonal Therapy (vs Short-term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on RTOG 9202

Gleason Pattern 5 is Associated With an Increased Risk for Metastasis Following Androgen Deprivation Therapy (ADT) and Radiation: An Analysis of RTOG 9202 and 9902

Diabetes and Cardiovascular Mortality in Men With Locally Advanced Prostate Cancer: Updated Analysis From RTOG 92-02

Surrogate End-points for Prostate Cancer Specific Survival: Superiority of the Interval to Biochemical Failure: An Analysis of RTOG 9202 and 9413

The Influence of Age as a Predictor of Outcome in Prostate Cancer Patients Treated on RTOG Trials

Cardiovascular Mortality Following Androgen Deprivation Therapy in Men With Locally Advanced Prostate Cancer: An Analysis of RTOG 85-31

Surrogate Endpoints for Prostate Cancer Survival: A Secondary Analysis of RTOG 9202

Tumor and treatment factors improving outcome in stage III-B cervix cancer

Carcinoma of the cervix: Patterns of care studies: Review of 1978, 1983, and 1988–1989 surveys

The impact of radiation dose on survival following conformal treatment of prostate cancer

65

Prognostic factors in carcinoma of the prostate— analysis of rtog study 75-06

65: Temporal Profile of Serum Testosterone With Goserelin Use and Cessation: Analysis of Radiation Therapy Oncology Group Protocol 92-02

2196

2196: Comparison of Two Types of Biochemical Failures Within the ASTRO and Phoenix Consensus Definitions in Patients Treated on RTOG 92–02 and 94–13

54 The radiation dose response of the human cervical spinal cord

1124

22

Post-radiotherapy PSA nadir remains highly predictive of outcome in men who are biochemically free of disease at 1.5 years post-treatment

Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with 3D conformal radiation therapy

Late GI and GU morbidity profiles in prostate cancer patients treated with 3D-CRT to 81-84 Gy by a 4-field beam arrangement

Highly predictive biochemical indicators of distant metastasis and death due to prostate cancer

Suchergebnisse filtern